1Experience reference and China's path of legislation on orphan drugs and medical devicesXU Ying-ling, YANG Yue2017-20262A review of China's rare disease drug policies and their implementation effectivenessCUI Na, LIU Kai, DONG Quan-liang, TIAN Li-juan2027-20353Practice and consideration on the management of human genetic resources in drug clinical research under new regulationsNI Qi, LIU Yi2036-20404Physiopathologic role of the proteasome and progress in the development of targeted drugsZUO Rui, ZHOU Qiu-hua, JI Xiao-jun, SU Jin-cai, XU Dan, WU Jian2041-20485The current situation,difficulties,and countermeasures of ethical review for termination of clinical trialsZHAO Xiao-yu, ZHOU Ji-yin2049-20566Clinical research progress on the impact of esketamine on the postoperative recovery quality in adult patienceGENG Zhi-yu, BAI Ming-xin2057-20617Application of organoids in endometrial physiological models,disease mechanisms and therapeutic researchTIAN Shu-ting, LIU Li, DENG Yi-fang2062-20678Prediction on the mechanism of agarwood sesquiterpene components in prevention and treatment of insomnia based on molecular dockingWANG Can-hong, GONG Bao, WU Yu-lan, MOU Jun-yu, CHENG Xiao-ling, WEI Jian-he2068-20759Effect of Massa Medicata Fermentata on gastrointestinal hormones and intestinal flora in mice with spleen deficiency constipation based on network pharmacologyLIANG Xue-juan, CHEN Ling-long, FENG Xiao-long, LIU Ju-li, PENG Yan-mei, TIAN Qi-xue2076-208610Determination of aerodynamic particle size distribution of revefenacin inhalation solutionCAO Ting, WANG Xue, YUAN Dan, ZHAO Wen-jie, WANG Min, LIU A-li2087-209311Bioequivalence of crisaborole ointment in Chinese healthy subjects under topical conditionsSUI Xin, WANG Hua-wei, LI Xiao-bin, WU Xiu-jun, LI Mei-ye, WANG Ning, WANG Wen-ping2094-209812Isolation and identification of sesquiterpenes and nitrogen-containing compounds in the water decoction of Curcumae Rhizoma-Sparganii Rhizoma and bioinformatics analysis on their anti-ovarian cancer effectLI Ming-xia, XU Guan-ling, SUN Meng-yu, ZHANG Feng, MA Jia-mu, YANG Yong-qi, YANG Yu-qing, YING Le-tian, YAO Jian-ling, CAO Yu, SHE Gai-mei2099-210813Cost-utility analysis of dupilumab vs omalizumab in the treatment of severe asthmaXU Nuo-ming, JIANG Xin-yue, HE Xiao-ning2109-211614Analysis of adverse reactions in blood system caused by fulvestrantMA Bing-jie, WANG Yu, CANG Ai-jun2117-212115Expert consensus on clinical application of Compound Phellodendron Liquid Coating for mixed hemorrhoids(2025 edition)YANG Hui-ju, LIU Dian-wen2122-2128 